Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Nice
NICE
$6.01B
| $7.8M | 0.01% |
50,263
+21,519
| +75% | +$3.28M |
|
|
AMNB
1602
DELISTED
American National Bankshares Inc
AMNB
| $7.8M | 0.01% |
197,041
+18,841
| +11% | +$702K |
|
1603
LPL Financial
LPLA
$29.1B
| $7.79M | 0.01% |
84,400
-3,400
| -4% | -$292K |
|
|
LN
1604
DELISTED
LINE Corporation
LN
| $7.77M | 0.01% |
158,460
-38,400
| -20% | -$1.64M |
|
1605
Orion Energy Systems
OESX
$77.9M
| $7.76M | 0.01% |
231,536
+49,560
| +27% | +$1.49M |
|
1606
Americold
COLD
$4.24B
| $7.72M | 0.01% |
220,188
-687,312
| -76% | -$25.3M |
|
1607
Ceragon Networks
CRNT
$197M
| $7.7M | 0.01% |
3,666,700
-454,800
| -11% | -$1.02M |
|
1608
Enel Chile
ENIC
$6.27B
| $7.67M | 0.01% |
1,614,773
-74,553
| -4% | -$322K |
|
1609
ArcBest
ARCB
$3.19B
| $7.66M | 0.01% |
277,339
+199,304
| +255% | +$5.76M |
|
1610
Daktronics
DAKT
$985M
| $7.65M | 0.01% |
1,256,200
-33,800
| -3% | -$226K |
|
|
TUP
1611
DELISTED
Tupperware Brands Corporation
TUP
| $7.64M | 0.01% |
890,455
-532,500
| -37% | -$5.81M |
|
1612
StealthGas
GASS
$350M
| $7.63M | 0.01% |
2,225,130
+28,000
| +1% | +$95.1K |
|
|
CDR
1613
DELISTED
Cedar Realty Trust, Inc
CDR
| $7.62M | 0.01% |
391,509
+43,856
| +13% | +$852K |
|
1614
BCB Bancorp
BCBP
$163M
| $7.62M | 0.01% |
552,579
+73,503
| +15% | +$976K |
|
1615
United Fire Group
UFCS
$1.39B
| $7.59M | 0.01% |
173,656
+3,117
| +2% | +$139K |
|
1616
China Yuchai International
CYD
$1.7B
| $7.56M | 0.01% |
567,454
+62,700
| +12% | +$842K |
|
1617
LXP Industrial Trust
LXP
$3.57B
| $7.54M | 0.01% |
142,040
-69,171
| -33% | -$3.7M |
|
1618
PRA Group
PRAA
$784M
| $7.53M | 0.01% |
207,300
+85,500
| +70% | +$3.03M |
|
|
KE
1619
Kimball Electronics
KE
$620M
| $7.52M | 0.01% |
428,375
-14,483
| -3% | -$238K |
|
|
RJET
1620
Republic Airways Holdings
RJET
$936M
| $7.5M | 0.01% |
55,944
+25,997
| +87% | +$3M |
|
1621
Franklin Covey
FC
$225M
| $7.5M | 0.01% |
232,603
+112,700
| +94% | +$4.08M |
|
|
APHA
1622
DELISTED
Aphria Inc. Common Shares
APHA
| $7.5M | 0.01% |
1,434,700
+1,112,800
| +346% | +$5.47M |
|
|
VIA
1623
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $7.47M | 0.01% |
161,821
+53,560
| +49% | +$2.68M |
|
|
MRLN
1624
DELISTED
Marlin Business Services Corp
MRLN
| $7.46M | 0.01% |
339,470
-14,130
| -4% | -$321K |
|
1625
HUTCHMED
HCM
$2.13B
| $7.45M | 0.01% |
297,200
+138,400
| +87% | +$3.03M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.